1099:HKG
Sinopharm Group Co Ltd
HK$14.85
arrow_downward
-0.47%(-0.070) 1D
Oct 7, 4:08:50 PM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1099...
Open
HK$14.93
High
HK$14.99
Low
HK$14.82
Mkt. cap
46.34B
Avg. vol.
5.17M
Volume
3.28M
Dividend
5.32%
Quarterly dividend
HK$0.20
Ex-dividend date
Jun 23, 2026
P/E ratio
5.58
52-wk high
HK$22.34
52-wk low
HK$14.55
EPS
HK$2.66
Shares outstanding
1.19B
No. of employees
90K
Open
HK$14.93
High
HK$14.99
Low
HK$14.82
Mkt. cap
46.34B
Avg. vol.
5.17M
Volume
3.28M
Dividend
5.32%
Quarterly dividend
HK$0.20
Ex-dividend date
Jun 23, 2026
P/E ratio
5.58
52-wk high
HK$22.34
52-wk low
HK$14.55
EPS
HK$2.66
Shares outstanding
1.19B
No. of employees
90K
News stories
From web sources and news partners
AD HOC NEWS
·
11 hours ago
Sinopharm stock faces a 2.95 percent interim profit drop
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
About Sinopharm Group Co Ltd